Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $3.88 Billion |
|---|---|
| Enterprise Value | $3.17 Billion |
| Annual dividend | $0.18 |
| Dividend yield | 1.85% |
| Earnings per Share | $-0.08 |
| Beta | 0.52 |
| Outstanding Shares | 398,520,900 |
| P/E Ratio | 97.3 |
|---|---|
| PEG | 213.41 |
| Price to Sales | 3.24 |
| Price to Book Ratio | 2.43 |
| Enterprise Value to Revenue | 2.56 |
| Enterprise Value to EBIT | 36.05 |
| Enterprise Value to Net Income | 77 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.07 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Shanghai Labway Clinical Laboratory Co., Ltd. provides a dual service offering: comprehensive medical laboratory services and the distribution of in vitro diagnostic (IVD) products. Established in 1993, the company is headquartered in Shanghai, China.